(Q71395944)
Statements
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation (English)
D M Karussis
Z Meiner
D Lehmann
J M Gomori
A Schwarz
A Linde